Cite Filings / STIM / 0000921895-26-000850
Feed Companies Filings Check
Sign in
SCHEDULE 13D

Beneficial Ownership Report

Neuronetics, Inc. · Filed 2026-03-31 · Acc 0000921895-26-000850

Documents 1

  • SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X02/primary_doc.xml

Around this filing

  • 2026-04-06 8-K Material agreement · Exit or restructuring costs · Executive or director change · Regulation FD disclosure
  • 2026-04-01 4 10% owner gave 337,312 shares (gift)
  • 2026-03-31 SCHEDULE 13D Beneficial Ownership Report
  • 2026-03-30 4 10% owner bought 385,442 shares at $1.25 ($481,803)
  • 2026-03-30 4 10% owner bought 500,000 shares at $1.35 ($675,000)
  • 2026-03-27 4 10% owner bought 150,000 shares at an average $1.41 ($211,000)
  • 2026-03-24 4 EVP, CFO and Treasurer sold 16,431 shares at $1.34 ($22,018)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13D_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…